Report highlights the results of studies into to the instrumentation and reagents utilised in research in the USA
The Science Advisory Board has just released a comprehensive summary of its recent studies.
This report highlights the results of studies members have taken since 2001 along with supporting graphics and member insights pertaining to the instrumentation and reagents utilised in their research.
Tamara Zemlo, director of scientific and medical communications, states that "It was clear from our recent site satisfaction survey that members of the Science Advisory Board really want to find out what their colleagues are saying regarding the techniques and technologies they employ.
We wanted to provide, in addition to the highlights cited in the Study Snapshots section that are posted regularly on the website, a thorough review of the data collected from these detailed studies".
This report includes a summary of protein science and proteomics as the next evolution of genomics.
This section highlights the top suppliers of the tools for these technologies along with specific needs of both large- and small-scale proteomic research in the areas of expression and purification, separation, visualisation, identification, and characterisation.
New and existing methods for accelerating drug discovery are explained in 'Tools of drug discovery'. This section reveals the cutting-edge technologies used in drug discovery, automated DNA sequencing, bioinformatics, DNA microarrays, bioassays, high throughput screening (HTS), and nuclear magnetic resonance (NMR).
The section on 'New tools for enabling discovery' highlights the top suppliers and methods involved with SNP genotyping technology, RNA interference technology, quantitative polymerase chain reaction (qPCR), toxicogenomics, cytokines, growth factors, along with the perceptions of brand in the life science market.
